Your browser doesn't support javascript.
loading
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma.
Krabbe, Laura-Maria; Eminaga, Okyaz; Shariat, Shahrokh F; Hutchinson, Ryan C; Lotan, Yair; Sagalowsky, Arthur I; Raman, Jay D; Wood, Christopher G; Weizer, Alon Z; Roscigno, Marco; Montorsi, Francesco; Bolenz, Christian; Novara, Giacomo; Kikuchi, Eiji; Fajkovic, Harun; Rapoport, Leonid M; Glybochko, Peter V; Zigeuner, Richard; Remzi, Mesut; Bensalah, Karim; Kassouf, Wassim; Margulis, Vitaly.
Afiliação
  • Krabbe LM; Department of Urology, University of Muenster Medical Center, Muenster, Germany; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
  • Eminaga O; Department of Urology, University Hospital of Cologne, Cologne, Germany; Department of Urology, Stanford University School of Medicine, Stanford, California.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Hutchinson RC; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
  • Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
  • Sagalowsky AI; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
  • Raman JD; Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Wood CG; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weizer AZ; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Roscigno M; Department of Urology, AO Papa Giovanni XXIII, Bergamo, Italy.
  • Montorsi F; Department of Urology, Vita Salute University, San Raffaele, Milan, Italy.
  • Bolenz C; Department of Urology, University of Ulm, Ulm, Germany.
  • Novara G; Department of Surgery, Oncology and Gastroenterology - Urologic Clinic, University of Padua, Padua, Italy.
  • Kikuchi E; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Fajkovic H; Department of Urology, General Hospital of St. Poelten, St. Poelten, Austria.
  • Rapoport LM; Department of Uronephrology and Reproductive Health, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Glybochko PV; Department of Uronephrology and Reproductive Health, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Zigeuner R; Department of Urology, Medical University of Graz, Graz, Austria.
  • Remzi M; Department of Urology, Landesklinikum Korneuburg, Korneuburg, Austria.
  • Bensalah K; Department of Urology, Bicêtre University Hospital, Le Kremlin Bicêtre, France.
  • Kassouf W; Department of Urology, McGill University Health Center, Montreal, Quebec, Canada.
  • Margulis V; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
J Urol ; 197(3 Pt 1): 580-589, 2017 03.
Article em En | MEDLINE | ID: mdl-27670916
PURPOSE: We developed a prognostic nomogram for patients with high grade urothelial carcinoma of the upper urinary tract after extirpative surgery. MATERIALS AND METHODS: Clinical data were available for 2,926 patients diagnosed with high grade urothelial carcinoma of the upper urinary tract who underwent extirpative surgery. Cox proportional hazard regression models identified independent prognosticators of relapse in the development cohort (838). A backward step-down selection process was applied to achieve the most informative nomogram with the least number of variables. The L2-regularized logistic regression was applied to generate the novel nomogram. Harrell's concordance indices were calculated to estimate the discriminative accuracy of the model. Internal validation processes were performed using bootstrapping, random sampling, tenfold cross-validation, LOOCV, Brier score, information score and F1 score. External validation was performed on an external cohort (2,088). Decision tree analysis was used to develop a risk classification model. Kaplan-Meier curves were applied to estimate the relapse rate for each category. RESULTS: Overall 35.3% and 30.7% of patients experienced relapse in the development and external validation cohort. The final nomogram included age, pT stage, pN stage and architecture. It achieved a discriminative accuracy of 0.71 and 0.76, and the AUC was 0.78 and 0.77 in the development and external validation cohort, respectively. Rigorous testing showed constant results. The 5-year relapse-free survival rates were 88.6%, 68.1%, 40.2% and 12.5% for the patients with low risk, intermediate risk, high risk and very high risk disease, respectively. CONCLUSIONS: The current nomogram, consisting of only 4 variables, shows high prognostic accuracy and risk stratification for patients with high grade urothelial carcinoma of the upper urinary tract following extirpative surgery, thereby adding meaningful information for clinical decision making.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Urológicas / Urotélio / Nomogramas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Urológicas / Urotélio / Nomogramas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article